KAEPY vs. RPRX
KAEPY (Kansai Electric Power Co Inc ADR) and RPRX (Royalty Pharma plc) are both stocks. KAEPY operates in Utilities - Renewable (Utilities), while RPRX operates in Biotechnology (Healthcare). Over the past 5 years, KAEPY returned 10.09%/yr vs 11.45%/yr for RPRX. Their 0.01 correlation means their historical movements had little consistent relationship.
Performance
KAEPY vs. RPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KAEPY achieves a -6.25% return, which is significantly lower than RPRX's 52.68% return.
KAEPY
- 1D
- -3.85%
- 1M
- 0.13%
- 6M
- 0.54%
- YTD
- -6.25%
- 1Y
- 20.19%
- 3Y*
- 8.22%
- 5Y*
- 10.09%
- 10Y*
- 5.38%
- ALL TIME*
- -9.09%
RPRX
- 1D
- -1.00%
- 1M
- 1.14%
- 6M
- 41.54%
- YTD
- 52.68%
- 1Y
- 60.83%
- 3Y*
- 26.97%
- 5Y*
- 11.45%
- 10Y*
- —
- ALL TIME*
- 7.03%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $33.72K | $27.07K | $24.04K | |
| $153.39M | $158.93M | $200.87M |
KAEPY vs. RPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
KAEPY Kansai Electric Power Co Inc ADR | -6.25% | 39.40% | -4.17% | 36.86% | -4.66% | 1.71% | -10.33% |
RPRX Royalty Pharma plc | 52.68% | 55.29% | -6.36% | -27.08% | 0.99% | -19.09% | 14.62% |
Correlation
The correlation between KAEPY and RPRX is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.09 |
Correlation (3Y) Balances recent behavior with more history. | 0.04 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.03 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.01 |
Fundamentals
KAEPY:
$16.63B
RPRX:
$25.13B
KAEPY:
¥172.82
RPRX:
$2.22
KAEPY:
6.83
RPRX:
26.34
KAEPY:
0.01
RPRX:
0.03
KAEPY:
0.64
RPRX:
8.93
KAEPY:
¥4.11T
RPRX:
$2.44B
KAEPY:
¥443.05B
RPRX:
$1.81B
KAEPY:
¥892.45B
RPRX:
$1.70B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KAEPY vs. RPRX — Risk / Return Rank
KAEPY
RPRX
KAEPY vs. RPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kansai Electric Power Co Inc ADR (KAEPY) and Royalty Pharma plc (RPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KAEPY | RPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.33 | ||
| Sortino ratioReturn per unit of downside risk | -2.65 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.45 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | 0.75 | 8.47 | -7.72 |
| Martin ratioReturn relative to average drawdown | 1.73 | 20.69 | -18.96 |
Loading charts...
Drawdowns
KAEPY vs. RPRX - Drawdown Comparison
The maximum KAEPY drawdown since its inception was -93.59%, which is greater than RPRX's maximum drawdown of -49.68%. Use the drawdown chart below to compare losses from any high point for KAEPY and RPRX.
Loading charts...
Drawdown Indicators
| KAEPY | RPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.59% | -49.68% | -43.91% |
Max Drawdown (1Y)Largest decline over 1 year | -26.70% | -7.38% | -19.32% |
Max Drawdown (3Y)Largest decline over 3 years | -44.41% | -20.67% | -23.74% |
Max Drawdown (5Y)Largest decline over 5 years | -44.41% | -41.98% | -2.43% |
Max Drawdown (10Y)Largest decline over 10 years | -54.33% | — | — |
Current DrawdownCurrent decline from peak | -84.34% | -2.57% | -81.77% |
Average DrawdownAverage peak-to-trough decline | -79.48% | -25.78% | -53.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.50% | 3.01% | +8.49% |
Volatility
KAEPY vs. RPRX - Volatility Comparison
Kansai Electric Power Co Inc ADR (KAEPY) has a higher volatility of 16.86% compared to Royalty Pharma plc (RPRX) at 7.73%. This indicates that KAEPY's price experiences larger fluctuations and is considered to be riskier than RPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KAEPY | RPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.86% | 7.73% | +9.13% |
Volatility (6M)Calculated over the trailing 6-month period | 40.00% | 15.78% | +24.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.89% | 22.90% | +26.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.17% | 23.86% | +23.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.15% | 26.84% | +13.31% |
Dividends
KAEPY vs. RPRX - Dividend Comparison
KAEPY has not paid dividends to shareholders, while RPRX's dividend yield for the trailing twelve months is around 1.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
KAEPY Kansai Electric Power Co Inc ADR | 0.00% | 1.30% | 1.72% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.71% |
RPRX Royalty Pharma plc | 1.56% | 2.28% | 3.29% | 2.85% | 1.92% | 1.71% | 0.60% | 0.00% | 0.00% | 0.00% |
Financials
KAEPY vs. RPRX - Financials Comparison
This section allows you to compare key financial metrics between Kansai Electric Power Co Inc ADR and Royalty Pharma plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KAEPY vs. RPRX - Profitability Comparison
KAEPY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Kansai Electric Power Co Inc ADR reported a gross profit of 50.69B and revenue of 1.13T. Therefore, the gross margin over that period was 4.5%.
RPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Royalty Pharma plc reported a gross profit of 0.00 and revenue of 631.00M. Therefore, the gross margin over that period was 0.0%.
KAEPY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Kansai Electric Power Co Inc ADR reported an operating income of 51.14B and revenue of 1.13T, resulting in an operating margin of 4.5%.
RPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Royalty Pharma plc reported an operating income of 563.00M and revenue of 631.00M, resulting in an operating margin of 89.2%.
KAEPY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Kansai Electric Power Co Inc ADR reported a net income of 40.59B and revenue of 1.13T, resulting in a net margin of 3.6%.
RPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Royalty Pharma plc reported a net income of 295.00M and revenue of 631.00M, resulting in a net margin of 46.8%.
Frequently Asked Questions
KAEPY and RPRX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KAEPY has higher volatility (16.86%) compared to RPRX (7.73%). In terms of maximum drawdown, KAEPY dropped -93.59% vs RPRX's -49.68%.
RPRX currently has the higher Sharpe Ratio (2.73 vs 0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KAEPY and RPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer